AU605584B2 - Method for the preparation of amidino-urea derivatives - Google Patents
Method for the preparation of amidino-urea derivativesInfo
- Publication number
- AU605584B2 AU605584B2 AU15980/88A AU1598088A AU605584B2 AU 605584 B2 AU605584 B2 AU 605584B2 AU 15980/88 A AU15980/88 A AU 15980/88A AU 1598088 A AU1598088 A AU 1598088A AU 605584 B2 AU605584 B2 AU 605584B2
- Authority
- AU
- Australia
- Prior art keywords
- dimethyl sulphoxide
- dimethylphenyl
- urea
- carbamate
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims description 30
- SQSPRWMERUQXNE-UHFFFAOYSA-N Guanylurea Chemical class NC(=N)NC(N)=O SQSPRWMERUQXNE-UHFFFAOYSA-N 0.000 title claims description 15
- 238000002360 preparation method Methods 0.000 title claims description 13
- RRHJHSBDJDZUGL-UHFFFAOYSA-N lidamidine Chemical compound CN=C(N)NC(=O)NC1=C(C)C=CC=C1C RRHJHSBDJDZUGL-UHFFFAOYSA-N 0.000 claims description 36
- 229960001760 dimethyl sulfoxide Drugs 0.000 claims description 35
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 23
- 238000006243 chemical reaction Methods 0.000 claims description 20
- CHJJGSNFBQVOTG-UHFFFAOYSA-N methylguanidine Chemical compound CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 claims description 18
- 239000000203 mixture Substances 0.000 claims description 11
- 239000011541 reaction mixture Substances 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 9
- -1 alkyl carbamate Chemical compound 0.000 claims description 9
- 150000002357 guanidines Chemical class 0.000 claims description 8
- 229910052739 hydrogen Inorganic materials 0.000 claims description 8
- 239000001257 hydrogen Substances 0.000 claims description 6
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 5
- 239000000010 aprotic solvent Substances 0.000 claims description 4
- YQLRKXVEALTVCZ-UHFFFAOYSA-N 2-isocyanato-1,3-dimethylbenzene Chemical compound CC1=CC=CC(C)=C1N=C=O YQLRKXVEALTVCZ-UHFFFAOYSA-N 0.000 claims description 3
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 3
- 239000004202 carbamide Substances 0.000 claims description 3
- 229940113088 dimethylacetamide Drugs 0.000 claims description 3
- QSACPWSIIRFHHR-UHFFFAOYSA-N dimethylphenyl isocyanide Natural products CC1=CC=CC(C)=C1C#N QSACPWSIIRFHHR-UHFFFAOYSA-N 0.000 claims description 3
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 claims description 3
- 239000003960 organic solvent Substances 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims description 2
- 125000003545 alkoxy group Chemical group 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 150000002367 halogens Chemical class 0.000 claims description 2
- AJFDBNQQDYLMJN-UHFFFAOYSA-N n,n-diethylacetamide Chemical compound CCN(CC)C(C)=O AJFDBNQQDYLMJN-UHFFFAOYSA-N 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 2
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 229960005045 lidamidine Drugs 0.000 description 30
- 239000000126 substance Substances 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000012948 isocyanate Substances 0.000 description 9
- 150000002513 isocyanates Chemical class 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 8
- 239000000725 suspension Substances 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000007795 chemical reaction product Substances 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 239000013078 crystal Substances 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 231100001261 hazardous Toxicity 0.000 description 3
- 238000011031 large-scale manufacturing process Methods 0.000 description 3
- QFLNEWLXKQAIIV-UHFFFAOYSA-N methyl n-(2,6-dimethylphenyl)carbamate Chemical compound COC(=O)NC1=C(C)C=CC=C1C QFLNEWLXKQAIIV-UHFFFAOYSA-N 0.000 description 3
- 239000000376 reactant Substances 0.000 description 3
- 239000012429 reaction media Substances 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 125000005907 alkyl ester group Chemical group 0.000 description 2
- 229940124537 antidiarrhoeal agent Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- BSCCSDNZEIHXOK-UHFFFAOYSA-N phenyl carbamate Chemical class NC(=O)OC1=CC=CC=C1 BSCCSDNZEIHXOK-UHFFFAOYSA-N 0.000 description 2
- AHAAHACLFHNTIF-UHFFFAOYSA-N phenyl n-(2,6-dimethylphenyl)carbamate Chemical compound CC1=CC=CC(C)=C1NC(=O)OC1=CC=CC=C1 AHAAHACLFHNTIF-UHFFFAOYSA-N 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- INMBONSHXVMDSX-UHFFFAOYSA-N [amino-[(2,6-dimethylphenyl)carbamoylamino]methylidene]-methylazanium;chloride Chemical compound Cl.CN=C(N)NC(=O)NC1=C(C)C=CC=C1C INMBONSHXVMDSX-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 239000003793 antidiarrheal agent Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 150000004283 biguanides Chemical class 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- IJAQDOIKWBEHFN-UHFFFAOYSA-N ethyl n-(2,6-dimethylphenyl)carbamate Chemical compound CCOC(=O)NC1=C(C)C=CC=C1C IJAQDOIKWBEHFN-UHFFFAOYSA-N 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 description 1
- 229940083094 guanine derivative acting on arteriolar smooth muscle Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- AHWALFGBDFAJAI-UHFFFAOYSA-N phenyl carbonochloridate Chemical compound ClC(=O)OC1=CC=CC=C1 AHWALFGBDFAJAI-UHFFFAOYSA-N 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
- C07C279/24—Y being a hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
METHOD FOR THE PREPARATION OF AMIDINO-UREA DERIVATIVES
The invention relates to a new method for the preparation of amidino-urea derivatives.
It is known that amidino-urea derivatives possess numerous favourable physiological properties [Fortschritte der Arzneimittelforschung 28, 1435 (1978)]. Of them 1-(2,6-dimethylphenyl)-2-(N-methylamidino)-urea (lidamidine) is of particular interest. The hydrochloride of this compound is
an excellent antidiarrhoeal agent with a still unknown mechanism of effect, which exerts much less undesired side effects than the commonly applied antidiarrhoeal substances. Several methods have been described in the literature for the preparation of amidino-urea derivatives. Depending on the nature and position of the substituents present, certain amidino-urea derivatives can be prepared by subjecting the respective biguanide compounds to acidic hydrolysis. The large scale applicability of this method is, however, rather restricted, since numerous undesired side reactions may occur simultaneously during the synthesis [Fortschritte der Arzneimittelforschung 28, 1436 (1978)].
Amidino-urea derivatives can also be prepared by reacting the respective isocyanates with guanidino derivatives (US patents Nos. 4,060,635, 4,147,804, 4,203,920 and
4,283,555). The reaction proceeds generally easily and provides the aimed compounds with good yields. It is, however, a disadvantage that phosgene, an extremely hazardous poison, is required for the preparation of the starting isocyanates, and the isocyanates themselves are also hazardous poisons.
The high reactivity of isocyanates also leads to inconveniences, since, on one hand, isocyanates are difficult to store and transport, and, on the other hand, the reaction with isocyanates frequently does not stop at the formation of the required end product but proceeds further and gets difficult or impossible to control. To avoid this latter problem the guanidine derivative is applied generally in a 100% excess, which increases the costs of production to a great extent. It is also known that isocyanates can be prepared from reactants other than phosgene and can be converted
directly into the desired amidino-urea derivatives (Spanish patents Nos. 546,126 and 548,902). Although the use of poisonous phosgene and the difficulties in the storage and transport of isocyanates can be avoided by these methods, both of them are much more sophisticated and expensive than those utilizing phosgene as starting substance. These methods can be applied essentially for laboratory purposes but not for large scale production.
Amidino-urea derivatives can also be prepared by reacting the appropriately substituted aromatic carbamates with guanidine derivatives (published South African patent application No. 78/1574), the yield is, however, very poor even when applying phenyl esters as starting substances. Several difficulties emerge at the isolation of the end products, too: difficult and sophisticated purification steps are required in order to separate the amidino-urea derivatives from the starting carbamates and phenol formed in the reaction. Considering that phenyl chloroformate, required as starting substance to prepare phenyl carbamates, is an expensive chemical, it is obvious that the above method cannot be applied for large scale production. The utilization of alkyl carbamates, which require much less expensive starting substances, is not even mentioned as an example in the cited reference. It is known, however, from other references dealing with related reactions of alkyl carbamates that the reactivity of the alkyl esters is so poor under such conditions that no successful reaction can be expected [J. Am. Chem. Soc. 76, 4458 (1954)].
Summing up, no method has been disclosed in the literature which could fit for all the requirements of the
large scale production of amidino-urea derivatives.
How it has been found, unexpectedly, that when an alkyl ester of an aromatic carbaminic acid is reacted with the appropriate guanidine derivative in the presence of a dipolar aprotic solvent, the reaction proceeds easily, and the required amidino-urea derivative is obtained with a good yield within a relatively short period of time.
Based on the above, the invention relates to a method for the preparation of an amidino-urea derivative of the general formula (I),
wherein
R1, R2 and R 3 each stand for hydrogen, halogen, lower alkyl, lower alkoxy , trifluoromethyl, nitro or optionally substituted amino , R4 is hydrogen or lower alkyl , and R5 is hydrogen or C1-10 alkyl, by reacting an alkyl carbamate of the general formula (II) ,
wherein R1, R2 and R3 are as defined above and R6 is a C1-1 alkyl group , with a guanidine derivative of the general formula (III) ,
wherein R4 and R5 are as defined above. According to the invention the reaction is performed in the presence of a bipolar aprotic solvent.
It is preferred to apply dimethyl formamide, dimethyl acetamide, dimethyl sulphoxide, hexamethylphosphoric acid triamide, diethyl acetamide or any mixture of these liquids as bipolar aprotic solvent.
The alkyl carbamate of the general formula (II) is reacted with the guanidine derivative of the general formula (III) generally in a molar ratio near to the equimolar value, preferably in a molar ratio of 1 : (0.8-1.25). The reaction is performed preferably under heating the reaction mixture. Since a lower alkanol splits off in the reaction, it is preferred to perform the reaction at a temperature which enables one to remove the thus formed alkanol from the mixture within a short period of time. The removal of the alkanol can also be facilitated by simultaneously lowering the pressure of the reaction.
The resulting compound of the general formula (I) is separated from the reaction mixture in a manner known per se. According to a preferred method the reaction mixture is poured into water, and the amidino-urea derivative, separated as a crystalline substance, is removed e.g. by filtration. Solvents other than water can also be applied as precipitating agents. The end products obtained are generally sufficiently pure, however, if desired, they can be purified by standard methods, e.g. by recrystallization, chromatography or salt
formation.
One can also proceed in such a way that the separated end product, optionally in undried state, is directly converted into its salt, and, if necessary, the salt is purified further. Any of the mineral and organic acids applicable for pharmaceutical purposes can be used in the salt formation step, of which hydrochloric acid is preferred.
The main advantages resulting from the method of the invention are as follows: - no poisonous and hazardous reactants (phosgene, isocyanates) are required;
- the reaction proceeds smoothly with good yields, and byproducts are formed only in insignificant amounts;
- there is no need for utilizing the guanidine derivative in large excess;
- the starting substances are less expensive than those applied before, thus the new method is more economical than the known ones.
It has also been found that when applying the method of the invention for the preparation of lidamidine and reacting N-methyl-guanldlne with a lower 2,6-dimethyl¬phenyl carbamate in the presence of dimethyl sulphoxide, an adduct (molecular compound) comprising lidamidine and dimethyl sulphoxide in a molar ratio of 1:1 is formed. The same adduct is obtained when reacting crude or pure lidamidine, produced optionally directly in the reaction medium, with dimethyl sulphoxide.
The lidamidine - dimethyl sulphoxide adduct is a new compound, a stable, crystalline substance melting at 160-162ºC . This compound can be prepared in extreme ly pure
state, and can be utilized for the preparation of highly pure lidamidine. The lidamidine - dimethyl sulphoxide adduct can be utilized, however, even as such for the preparation of pharmaceutical compositions, since the small amount of dimethyl sulphoxide present is physiologically tolerable.
Based on the above, the invention also relates to a method for the preparation of a lidamidine - dimethyl sulphoxide adduct. According to the invention one proceeds in such a way that lidamidine, prepared optionally directly in the reaction mixture, is reacted with dimethyl sulphoxide optionally in the presence of one or more inert organic solvent(s).
The reaction can be performed most simply in such a way that lidamidine is suspended in dimethyl sulphoxide under stirring, and the resulting adduct is separated from the reaction mixture preferably by filtration. One can also proceed in such a way that lidamidine base is dissolved or suspended first in an inert organic solvent, and the required amount of dimethyl sulphoxide, preferably at least one molar equivalent calculated for lidamidine, is added to this solution or suspension in one or more portions.
Lidamidine can also be prepared directly in the reaction mixture. One can proceed e.g. in such a way that a salt of lidamidine is applied as starting substance, and lidamidine base is liberated from its salt directly in dimethyl sulphoxide or in a mixture of dimethyl sulphoxide with one or more inert solvent(s). According to another method 2,6-dimethylphenyl-isocyanate, phenyl 2, 6-dimethylphenyl-carbamate or a lower alkyl 2,6-dimethylphenyl-carbamate is reacted with N-methyl-guanidine in the presence of
dimethyl sulphoxide, whereupon lidamidine, which forms in the reaction mixture, Immediately converts into the respective dimethyl sulphoxide adduct. A particular advantage of this latter method is that the resulting adduct is extremely pure, free of any contaminations originating from the starting substances applied in the preparation of lidamidine.
As mentioned above, the lidamidine - dimethyl sulphoxide adduct can be converted directly into pharmaceutical compositions, such as tablets, capsules, suspensions, etc., by routine pharmacotechnological methods utilizing conventional pharmaceutical additives (e.g. carriers, diluents or other auxiliary agents).
The lidamidine - dimethyl sulphoxide adduct can be converted into lidamidine by reacting it with water. In this operation lidamidine is obtained in particularly pure state. This method is also embraced by the scope of the invention.
The lidamidine - dimethyl sulphoxide adduct is decomposed with water generally at 0-100°C, preferably at 20-80°C. It is preferred to apply at least one molar equivalent of water for the reaction. The upper limit of water to be added is not decisive and is determined essentially by economical factors. The resulting lidamidine is separated from the mixture by a method known per se.
The invention is elucidated in detail by the aid of the following non-limiting Examples.
Example 1
A mixture of 7.17 g (0.04 mole) of methyl 2,6-dimethylphenyl-carbamate, 3.21 g (0.044 mole) of methyl-guanidine and 15 cm3 of dimethyl formamide is warmed to 100°C with stirring. Methanol which forms in the reaction is re moved continuously at a pressure of 100 mmHg. At the end of the reaction the mixture is stirred for additional one hour, thereafter it is cooled to room temperature, poured into 160 cm3 of cold water, and the aqueous mixture is stirred at 10-15°C for 2 hours. The separated precipitate is filtered off, auctioned, and then washed with deionized water and finally with a small amount of acetone. The resulting crude product is dissolved in 80 cm3 of methanol, the solution is decolourized with a small amount of activated carbon, filtered, and the filtrate is acidified to pH 2 with methanolic hydrogen chloride solution. The solvent is removed under reduced pressure, and the residue is triturated with acetone. The precipitate is filtered off, suctioned, washed with a small amount of acetone and then with ether, and dried. 1-(2,6-Dimethylphenyl)-3-(N-methylamidino)-urea hydrochloride is obtained; m.p.: 194-197°C. The IR spectrum of the product is identical with that of the authentic sample.
Example 2
One proceeds as described in Example 1 with the difference that 15 cm3 of hexamethylphosphoric acid triamide are utilized as reaction medium, and the mixture is maintained at 100°C for 2 hours. 6.87 g (78.1 %) of 1-(2,6-dimethylphenyl)-3-(N-methylamidino)-urea are obtained. The hydrochloride of the product is identical with the compound obtained according to Example 1.
Example 3
A suspension of 80.5 g (0.45 mole ) of methyl 2, 6-dimethylpheny l-carbamate and 36.55 g (0.5 mole ) of methylguanidine in 170 cur of dimethyl sulphoxide is heated to 100°C with stirring, and stirred at this temperature for one hour. The reaction mixture is processed as described in Example 1 with the difference that salt formation is omitted. 86.58 g (86.5 %) of 1- (2, 6-dimethylphenyl)-3- (N-methylamidino ) -urea are obtained. Example 4
7.28 g (0.037 mole ) of ethyl 2, 6-dimethylphenyl-carbamate are reacted with 3.21 g (0.044 mole ) of methylguanidine in 15 cm3 of dimethyl sulphoxide as described in
Example 3. 6.69 g (80.6 %) of 1- (2, 6-dimethylphenyl)-3-(N-methylamidino)-urea are obtained.
Example 5
One proceeds as described in Example 1 with the difference that 15 cm3 of dimethyl acetamide are applied as reaction medium and the reaction is performed for 2 hours. The mixture is processed as described in Example 1. 6.06 g (68.8 %) of 1-(2,6-dimethy1phenyl)-3-(N-methylamidino)-urea are obtained. The hydrochloride of the product is identical with the compound prepared according to Example 1. Example 6 7.36 g (0.050 mole) of 2,6-dimethylphenyl-isocyanate are added dropwise, at room temperature, to a stirred suspension of 4.04 g (0.055 mole) of N-methylguanidine in 20 cm3 of dimethyl sulphoxide. The white, crystalline lidamidine - dimethyl sulphoxide adduct separates slowly during the addition of the reactant. The reaction mixture is
stirred for additional one hour, thereafter the crystals are filtered off, washed with a small amount of cold methanol and dried. 14.80 g (99 %) of lidamidine - dimethyl sulphoxide adduct are obtained; m.p.: 160-162°C. Analysis: calculated: C: 52.30%, H: 7.37%, N: 18.77 %, S: 10.73 %; found: C: 52.00%, H: 7-53%, N: 18.90 %, S: 11.51 %.
Example 7
3.38 g (0.014 mole) of phenyl 2,6-dimethylphenyl- carbamate are added in portions to a stirred suspension of
1.10 g (0.015 mole) of N-methyl-guanidine in 6 cm3 of dimethyl sulphoxide. Lidamidine - dimethyl sulphoxide adduct separates immediately. The reaction mixture is stirred for additional one hour, thereafter the crystals are filtered off, washed with methylene chloride and dried. 4.26 g (97 %) of lidamidine - dimethyl sulphoxide adduct are obtained. The product is homogeneous when examined by thin layer chr matography and melts at 160-162°C. Example 8 A suspension of 36.55 g (0.5 mole) of N-methylguanidine and 80.5 g (0.45 mole) of methyl 2,6-dimethylphenyl-carbamate in 170 cm3 of dimethyl sulphoxide is warmed to 100°C with stirring. The crystalline product starts to separate during the warming period. The mixture is stirred at 100°C for one hour, thereafter cooled to room temperature, the crystals are filtered off, washed with dichloromethane and dried. 131.2 g (97.7 %) of lidamidine - dimethyl sulphoxide adduct, melting at 160-162°C, are obtained. The purity grade of the product is identical with that obtained according to Example 6.
Example 9
100 g of lidamidine - dimethyl sulphoxide adduct are suspended in 700 cm3 of deionized water, and the suspension is stirred at 50°C for 0.5 hour. Thereafter the suspension is cooled to room temperature, the separated white crystalline substance is filtered off, washed with deionized water and dried. 71.8 g (97.2 %) of lidamidine are obtained.
Claims
1. A method for the preparation of an amidino-urea derivat ive of the general formula (I) ,
wherein R1, R2 and R3 each stand for hydrogen, halogen, lower alkyl , lower alkoxy, trifluoromethyl, nitro or optionally substituted amino ,
R4 is hydrogen or lower alkyl , and R5 is hydrogen or C1-10 alkyl, by reacting an alkyl carbamate of the general formula (ll) ,
wherein R1, R2 and R3 are as defined above and R6 is a C1-3 alkyl group, with a guanidine derivative of the general formula (III) ,
wherein R4 and R5 are as defined above, characterized in that the reaction is performed in the presence of a bipolar aprotic solvent.
2. A method as claimed in claim 1, characterized in that dimethyl formamide, dimethyl acetamide, dimethyl sulphoxide, hexamethylphosphoric triamide, diethyl acetamide or a mixture thereof is applied as solvent.
3. A method as claimed in claim 1 or 2, characterized in that 0.8-1.25 moles of a guanidine derivative of the general formula (III) are applied for 1 mole of a carbamate of the general formula (ll).
4. A method as claimed in any of claims 1 to 3, characterized in that the reaction is performed at a temperature between room temperature and the temperature required to remove the alcohol formed in the reaction.
5. A method for preparing an adduct of 1-(2,6-dimethylphenyl)-3-(N-methylamidino)-urea and dimethyl sulphoxide, characterized in that 1-(2,6-dimethylphenyl)-3-(N-methylamidino)-urea, prepared optionally directly in the reaction mixture, is reacted with dimethyl sulphoxide optionally in the presence of one or more inert organic solvent(s), preferably a lower alkanol. 6. A method as claimed in claim 5, characterized in that 2,
6-dimethylphenyl-isocyanate is reacted with N-methylguanidine in the presence of dimethyl sulphoxide.
7. A method as claimed in claim 5, characterized in that a lower alkyl 2,6-dimethylphenyl-carbamate is reacted with N-methyl-guanidine in the presence of dimethyl sulphoxide.
8. A method as claimed in claim 7, characterized in that the lower alkyl 2,6-dimethylphenyl-carbamate is methyl 2,6-dimethyIphenyl-carbamate.
9. A method for the preparation of 1-(2,6-dimethylphenyl)-3-(N-methylamidino)-urea, characterized in that an adduct of 1-(2,6-dimethyIphenyl)-3-(N-methylamidino)-urea and dimethyl sulphoxide is decomposed.
10. A method as claimed in claim 9, characterized in that the adduct is decomposed in the presence of water at a temperature exceeding room temperature.
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU160487A HU198177B (en) | 1987-04-10 | 1987-04-10 | Process for producing molecular compound of 1-(2,6-dimethylphenyl)-3-(n-methylamidino)-urea with dimethylsulfoxide |
| HU1605/87 | 1987-04-10 | ||
| HU160587A HU198178B (en) | 1987-04-10 | 1987-04-10 | Process for producing 1-(2,6-dimethylphenyl)-3-(n-methylamidino)-urea |
| HU160387A HU198176B (en) | 1987-04-10 | 1987-04-10 | Process for producing amidino urea derivatives |
| HU1604/87 | 1987-04-10 | ||
| HU1603/87 | 1987-04-10 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU1598088A AU1598088A (en) | 1988-11-04 |
| AU605584B2 true AU605584B2 (en) | 1991-01-17 |
Family
ID=27269965
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU15980/88A Expired - Fee Related AU605584B2 (en) | 1987-04-10 | 1988-04-08 | Method for the preparation of amidino-urea derivatives |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0325620A1 (en) |
| KR (1) | KR910008221B1 (en) |
| AU (1) | AU605584B2 (en) |
| FI (1) | FI885700A0 (en) |
| WO (1) | WO1988007990A1 (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU575132B2 (en) * | 1985-02-15 | 1988-07-21 | Rorer International (Overseas) Inc. | Preperation of amidinoureas |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT281854B (en) * | 1966-07-07 | 1970-06-10 | Wellcome Found | Process for the preparation of new amidinoureas or their acid addition salts |
| US4060635A (en) * | 1975-03-31 | 1977-11-29 | William H. Rorer, Inc. | Amidinoureas for treating diarrhea |
| US4283555A (en) * | 1973-07-16 | 1981-08-11 | William H. Rorer, Inc. | Amidinoureas |
| US4147804A (en) * | 1975-03-31 | 1979-04-03 | William H. Rorer, Inc. | Amidinourea local anesthetics |
| US4203920A (en) * | 1975-03-31 | 1980-05-20 | William H. Rorer, Inc. | Amidinoureas |
| CH631699A5 (en) * | 1978-03-29 | 1982-08-31 | Rorer Inc William H | Process for the preparation of amidinoureas |
| US4440949A (en) * | 1979-01-08 | 1984-04-03 | William H. Rorer, Inc. | Amidinoureas |
-
1988
- 1988-04-08 KR KR1019880701357A patent/KR910008221B1/en not_active Expired
- 1988-04-08 AU AU15980/88A patent/AU605584B2/en not_active Expired - Fee Related
- 1988-04-08 WO PCT/HU1988/000017 patent/WO1988007990A1/en not_active Application Discontinuation
- 1988-04-08 EP EP88903333A patent/EP0325620A1/en not_active Withdrawn
- 1988-12-08 FI FI885700A patent/FI885700A0/en not_active IP Right Cessation
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU575132B2 (en) * | 1985-02-15 | 1988-07-21 | Rorer International (Overseas) Inc. | Preperation of amidinoureas |
Also Published As
| Publication number | Publication date |
|---|---|
| KR890700572A (en) | 1989-04-25 |
| AU1598088A (en) | 1988-11-04 |
| EP0325620A1 (en) | 1989-08-02 |
| FI885700A7 (en) | 1988-12-08 |
| KR910008221B1 (en) | 1991-10-12 |
| WO1988007990A1 (en) | 1988-10-20 |
| FI885700A0 (en) | 1988-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0923554B1 (en) | N-benzylpiperidine and tetrahydropyridine derivatives | |
| US20120041044A1 (en) | Process for the preparation of carvedilol and its enantiomers | |
| WO1991001957A1 (en) | Resolution of racemic mixtures | |
| US6706890B2 (en) | Method for producing oxindoles | |
| CA1310017C (en) | Process for the preparation of 2, 6-dichlorodiphenylamino-acetic acid derivatives | |
| GB2106499A (en) | Method for making benzoylphenylureas | |
| AU605584B2 (en) | Method for the preparation of amidino-urea derivatives | |
| US4359416A (en) | Process for preparing L-carnosine | |
| JP4097291B2 (en) | Method for producing substituted valinamide derivative | |
| EP0481118B1 (en) | A method for producing butyl 3'-(1H-tetrazol-5-yl) oxanilate | |
| US5082969A (en) | Industrial process for obtaining an aryloxypropanolamine | |
| CN101155795B (en) | Method for the production of substituted thiophenesulfonyl isocyanates | |
| US5728834A (en) | Process for preparation of 4-aryl-1,2,4-triazol-3-ones | |
| US7728147B2 (en) | Detomidine hydrochloride crystallization method | |
| US6121492A (en) | Method for preparing 2-trifluoro-methoxy-aniline | |
| US5565575A (en) | Method for the production of 5-cyclohexylmethylhydantoin derivatives | |
| JP3311372B2 (en) | Method for producing 3-N, N-dialkylaminophenol derivative | |
| JPS6342617B2 (en) | ||
| NO885116L (en) | PROCEDURE FOR THE PREPARATION OF AMIDINOUREAD DERIVATIVES. | |
| US4945161A (en) | Process for the preparation of N,N'-bis-(2-hydroxy-ethyl) piperazine | |
| JPH05117214A (en) | Production of diphenylamine derivative | |
| US4304929A (en) | Process for preparing 4-(n-hexadecylamino)-benzoic acid | |
| HU193851B (en) | Process for preparing 1-(chlorcarbonyl)-3-(3,5-dichlorphenyl)-hydantoin | |
| JPH0987288A (en) | Method for purifying 1,3-bis (3-aminopropyl) -1,1,3,3-tetraorganodisiloxane | |
| JPH07258229A (en) | Production of 2-phenylbenzotriazole compound |